Sofía Scévola

Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

Daniel K. Nomah, Juliana Reyes‐Urueña, Yesika Díaz et al. · The Lancet HIV · 2021 · 110 citations · Full text

Public Health, Health Sciences, Infectious Diseases +17

Measurement of total and unbound bictegravir concentrations in plasma and cerebrospinal fluid by UHPLC-MS/MS

Raül Rigo‐Bonnin, Juan Tiraboschi, Marta Álvarez-Álvarez et al. · Journal of Pharmaceutical and Biomedical Analysis · 2020 · 23 citations

Pharmacy, Pharmacokinetics, Pharmacology +6

Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial

Lucía Bailón, José Moltó, Adrián Curran et al. · Nature Communications · 2025 · 22 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Dynamics of the Decay of Human Immunodeficiency Virus (HIV) RNA and Distribution of Bictegravir in the Genital Tract and Rectum in Antiretroviral-naive Adults Living With HIV–1 Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (Spanish HIV/AIDS Research Network, PreEC/RIS 58)

Arkaitz Imaz, Juan Tiraboschi, Jordí Niubó et al. · Clinical Infectious Diseases · 2020 · 20 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +17

Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study

Daniel K. Nomah, Juliana Reyes‐Urueña, Yesika Díaz et al. · Journal of Antimicrobial Chemotherapy · 2022 · 20 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +17